Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • ID: 3849628
  • Report
  • Region: Global
  • 302 Pages
  • Frost & Sullivan
1 of 4
Emerging Business Models Drive Transformation

FEATURED COMPANIES

  • Aenova
  • Catalent
  • Consort Medical
  • DTP Laboratories
  • Famar
  • Fareva
  • MORE
The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients (APIs) and intermediates; and finished dose formulations (FDFs), further segmented by solid, liquid and semi-solid, and injectable doses—and to understand the value chain from clinical to commercial, and drug substrate to final drug product of the CMOs, biotech, and pharma companies.

Additional goals are to analyze the dynamics catalyzing growth, profile organizations presenting significant opportunities, and outline industry consolidation trends that will continue shaping the market. The base year of analysis is 2015 and forecasts run from 2016 to 2020.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Aenova
  • Catalent
  • Consort Medical
  • DTP Laboratories
  • Famar
  • Fareva
  • MORE
1. Executive Summary
  • Key Findings-Pharmaceutical CMO Market
  • Scope and Geographic Segmentation
  • Market Segmentation
  • Methodology
  • Key Questions This Study Will Answer
  • Market Engineering Measurements
  • Global Manufacturing Footprint-Key CMO Companies
  • Transformation of Industry Ecosystem
  • Trends for the FDF CMO Market
  • Trends for the API and Intermediates CMO Market
  • Key Technology Trends-Preference for Disposable Technologies
  • Key Technology Trends-Rising Demand of Lyophilization
  • Key Investment Trends
  • Game-changing Companies
  • Customer Segment Revenue Contribution Analysis
  • 8 Big Market Themes for Contract Manufacturing
2. Global CMO Market Landscape
  • Total Pharmaceutical CMO Market Revenue Forecast
  • Revenue Forecast Discussion
  • API and Intermediates CMO Market Overview
  • FDF CMO Market Overview
  • Role of CMOs in the Pharmaceutical Manufacturing Value Chain
  • API and Intermediates and FDF Industry Ecosystem
  • Demand and Market Acceptance of Customers’ Products
  • Changing Business Model-Rise in Virtual Pharma
  • Virtual Pharma-Change Makers in Pharma and Biotech Outsourcing Ecosystem
  • Key Characteristics Influencing CMO Selection
  • New Business Models
  • Comparative Capability Analysis of Key Participants in the Pharma/ Biotech Contract Outsourcing Market
  • Global CMO Key Market Trends
  • Key Technology Trends-Inclination towards Continuous Manufacturing
  • Key Technology Trends-Prominence of Gamma Sterilization
  • Key Technology Trends-Rising Acceptance of Process Analytical Technologies (PAT)
  • Key Market Drivers
  • Key Market Restraints
3. Competitive Playbook
  • Snapshot of Competitive Landscape
  • Snapshot of Competitive Landscape
  • CMO Expansions in Products, Clinical Services, and Capacity Offerings
  • Differential Revenue Growth
  • Uncertainty Matrix-Mapping of Key CMO Industry Uncertainties
  • Possible Industry Overcapacity
  • 10 Companies to Watch and Why
4. Key Merger, Acquisition, and Partnership Agreements of the Contract Manufacturing Markets
  • Key Mergers and Acquisitions
  • Notable Mergers and Acquisitions-CMO Industry on a Consolidation Spree
  • Key Merger, Acquisition, and Partnership Agreements
  • Key FDF CMO Segment Strategic Collaborations
  • Key API and Intermediates Segment Strategic Collaborations
5. Forecast and Trends-Total Pharmaceutical CMO Market
  • Market Engineering Measurements
  • Forecast Assumptions
  • Total Pharmaceutical CMO Market Revenue Forecast
  • Revenue Forecast Discussion
  • Total Pharmaceutical CMO Market Percent Revenue Forecast by Region
  • Total Pharmaceutical CMO Market Revenue Forecast by Region
6. Total Pharmaceutical CMO Market Forecast by Service Type
  • Total Pharmaceutical CMO Market Percent Revenue Forecast by Service Type
  • Total Pharmaceutical CMO Market Revenue Forecast by Service Type
  • Revenue Forecast Discussion
7. Global API and Intermediates CMO Market Breakdown
  • API and Intermediates CMO Market Overview
  • Value Chain of Pharmaceutical Manufacturing
  • Market Segmentation
  • API and Intermediates CMO Market Revenue Forecast
  • API and Intermediates CMO Market Percent Revenue Breakdown by Geographic Region
  • API CMO Market Percent Revenue Breakdown by Synthesis Route
  • API and Intermediates CMO Market Revenue Forecast by Synthesis Route
  • API and Intermediates CMO Market Percent Revenue Breakdown by Customer Base
  • API and Intermediates CMO Market Revenue Breakdown by Customer Base
  • Revenue Forecast Discussion
8. Global FDF CMO Market Breakdown
  • Market Segmentation
  • FDF CMO Market Percent Revenue Breakdown by Geographic Region
  • FDF CMO Market Percent Revenue Forecast by Dosage Form
  • FDF CMO Market Percent Revenue Breakdown by Patent Exclusivity Status
  • FDF CMO Market Revenue Forecast
  • FDF CMO Market Percent Revenue Forecast by Dosage Form
  • FDF CMO Market Revenue Forecast by Dosage Form
  • Revenue Forecast Discussion
9. Market Share and Competitive Analysis
  • Global FDF CMO Market Share Analysis
  • API and Intermediates CMO Market-Competitive Structure
  • Key CMO Breakdown by APIs and FDFs
10. United States Breakdown
  • Market Overview
  • Market Analysis
  • Market Engineering Measurements
  • US Pharmaceutical CMO Market Revenue Forecast
  • US Pharmaceutical CMO Market Revenue Forecast by Service Type
11. US API and Intermediates CMO Market
  • US API and Intermediates CMO Market Revenue Forecast
  • Revenue Forecast Discussion
12. US FDF CMO Market Breakdown
  • US FDF CMO Market Revenue Forecast
  • Revenue Forecast Discussion
  • US Solid Dose Formulations Segment Revenue Forecast
  • US Solid Dose Formulations Segment Revenue Forecast Discussion
  • US Liquid and Semi-solid Dose Formulations Segment Revenue Forecast
  • US Liquid and Semi-solid Dose Formulations Segment Revenue Forecast Discussion
  • US Injectable Dose Formulations Segment Revenue Forecast
  • US Injectable Dose Formulations Segment Revenue Forecast Discussion
  • Pricing Analysis
  • PESTLE Analysis
13. US-Key Companies to Watch
  • Patheon
  • Patheon-Major Partnerships and Agreements
  • Catalent
  • Catalent-Major Partnerships and Agreements
  • Baxter Biopharma Solutions
14. Western Europe Breakdown
  • Market Overview
  • Market Analysis
  • Market Engineering Measurements
  • Western European Pharmaceutical CMO Market Revenue Forecast
  • Western European Pharmaceutical CMO Market Revenue Forecast by Service Type
  • Western European FDF CMO Market Revenue Forecast by Dosage Form
  • Western Europe Revenue Forecast Discussion
15. Western Europe API and Intermediates CMO Market Breakdown
  • Western Europe API and Intermediates CMO Market Revenue Forecast
  • Western Europe API and Intermediates CMO Market Revenue Forecast Discussion
16. Western Europe FDF CMO Market Breakdown
  • Western Europe FDF CMO Market Revenue Forecast
  • Solid Dose Formulations Segment Revenue Forecast
  • Solid Dose Formulations Segment Revenue Forecast Discussion
  • Liquid and Semi-solid Dose Formulations Segment Revenue Forecast
  • Liquid and Semi-solid Dose Formulations Segment Revenue Forecast Discussion
  • Injectable Dose Formulations Segment Revenue Forecast
  • Injectable Dose Formulations Segment Revenue Forecast Discussion
  • Pricing Analysis
  • PESTLE Analysis
17. Breakdown by Key Western Europe Countries
  • Market Segmentation for Western Europe Breakdown
 18. Germany Breakdown
  • Germany FDF CMO Market Revenue Forecast
  • Germany FDF CMO Market Revenue Forecast by Dosage Form
  • Germany Solid Dose Formulations Segment Revenue Forecast
  • Germany Liquid and Semi-solid Dose Formulations Segment Revenue Forecast
  • Germany Injectable Dose Formulations Segment Revenue Forecast
19. UK Breakdown
  • UK FDF CMO Market Revenue Forecast
  • UK FDF CMO Market Revenue Forecast by Dosage Form
  • UK Solid Dose Formulations Segment Revenue Forecast
  • UK Liquid and Semi-solid Dose Formulations Segment Revenue Forecast
  • UK Injectable Dose Formulations Segment Revenue Forecast
20. France Breakdown
  • France FDF CMO Market Revenue Forecast
  • France FDF CMO Market Revenue Forecast by Dosage Form
  • France Solid Dose Formulations Segment Revenue Forecast
  • France Liquid and Semi-solid Dose Formulations Segment Revenue Forecast
  • France Injectable Dose Formulations Segment Revenue Forecast
21. Italy Breakdown
  • Italy FDF CMO Market Revenue Forecast
  • Italy FDF CMO Market Revenue Forecast by Dosage Form
  • Italy Solid Dose Formulations Segment Revenue Forecast
  • Italy Liquid and Semi-solid Dose Formulations Segment Revenue Forecast
  • Italy Injectable Dose Formulations Segment Revenue Forecast
22. Spain Breakdown
  • Spain FDF CMO Market Revenue Forecast
  • Spain FDF CMO Market Revenue Forecast by Dosage Form
  • Spain Solid Dose Formulations Segment Revenue Forecast
  • Spain Liquid and Semi-solid Dose Formulations Segment Revenue Forecast
  • Spain Injectable Dose Formulations Segment Revenue Forecast
23. Scandinavia Breakdown
  • Scandinavia FDF CMO Market Revenue Forecast
  • Scandinavia FDF CMO Market Revenue Forecast by Dosage Form
  • Scandinavia Solid Dose Formulations Segment Revenue Forecast
  • Scandinavia Liquid and Semi-solid Dose Formulations Segment Revenue Forecast
  • Scandinavia Injectable Dose Formulations Segment Revenue Forecast
24. Benelux Breakdown
  • Benelux FDF CMO Market Revenue Forecast
  • Benelux FDF CMO Market Revenue Forecast by Dosage Form
  • Benelux Solid Dose Formulations Segment Revenue Forecast
  • Benelux Liquid and Semi-solid Dose Formulations Segment Revenue Forecast
  • Benelux Injectable Dose Formulations Segment Revenue Forecast
25. Western Europe-Key Companies to Watch
  • Aenova)
  • Aenova-Major Partnerships and Agreements
  • Famar
  • Famar-Major Partnerships and Agreements
  • Fareva
  • Fareva-Major Partnerships and Agreements
  • DTP Laboratories
  • DPT Laboratories-Major Partnerships and Agreements
  • Vetter Pharma
  • Vetter Pharma-Major Partnerships and Agreements
  • Consort Medical (Aesica/Bespak)
  • Consort Medical
  • Consort Medical-Major Partnerships and Agreements
  • Recipharm
  • Recipharm-Major Partnerships and Agreements
26. APAC Breakdown
  • Market Overview
  • Market Engineering Measurements
  • APAC Pharmaceutical CMO Market Revenue Forecast
  • APAC Pharmaceutical CMO Market Revenue Forecast by Service Type
  • APAC Revenue Forecast Discussion
27. APAC API and Intermediates CMO Market Breakdown
  • APAC API and Intermediates CMO Market Revenue Forecast
  • APAC API and Intermediates CMO Market Revenue Forecast Discussion
28. APAC FDF CMO Market Breakdown
  • APAC FDF CMO Market Revenue Forecast
  • APAC FDF CMO Market Percent Revenue Forecast by Dosage Form
  • APAC FDF CMO Market Revenue Forecast by Dosage Form
  • APAC FDF CMO Market Revenue Forecast Discussion
  • Pricing Analysis
  • PESTLE Analysis
29. Breakdown by Key APAC Countries
  • Market Segmentation for APAC Breakdown
30. China Breakdown
  • Market Summary-China
  • China Pharmaceutical CMO Market Revenue Forecast
  • China Pharmaceutical CMO Market Revenue Forecast by Service Type
  • China API and Intermediates CMO Market Revenue Forecast
  • China FDF CMO Market Revenue Forecast
  • China FDF CMO Market Revenue Forecast by Dosage Form
  • China Solid Dose Formulations Segment Revenue Forecast
  • China Liquid and Semi-solid Dose Formulations Segment Revenue Forecast
  • China Injectable Dose Formulations Segment Revenue Forecast
  • China Segment Discussion
  • Huapont Pharm Co., Ltd
  • Huapont Pharm Co., Ltd-Major Partnerships and Agreements
31. India Breakdown
  • Market Summary-India
  • India Pharmaceutical CMO Market Revenue Forecast
  • India Pharmaceutical CMO Market Revenue Forecast by Service Type
  • India API and Intermediates CMO Market Revenue Forecast
  • India FDF CMO Market Revenue Forecast
  • India FDF CMO Market Revenue Forecast by Dosage Form
  • India Solid Dose Formulations Segment Revenue Forecast
  • India Liquid and Semi-solid Dose Formulations Segment Revenue Forecast
  • India Injectable Dose Formulations Segment Revenue Forecast
  • India Segment Discussion
  • Dr. Reddy’s Laboratories-Custom Pharma Services
  • Dr. Reddy’s Laboratories Custom Pharma Services-Major Partnerships and Agreements
32. Japan Breakdown
  • Market Summary-Japan
  • Japan Pharmaceutical CMO Market Revenue Forecast
  • Japan Pharmaceutical CMO Market Revenue Forecast by Service Type
  • Japan API and Intermediates CMO Market Revenue Forecast
  • Japan FDF CMO Market Revenue Forecast
  • Japan FDF CMO Market Revenue Forecast by Dosage Form
  • Japan Solid Dose Formulations Segment Revenue Forecast
  • Japan Liquid and Semi-solid Dose Formulations Segment Revenue Forecast
  • Japan Injectable Dose Formulations Segment Revenue Forecast
  • Japan Segment Discussion
  • Nipro Pharma Corporation
  • Nipro Pharma Corporation-Custom Pharma Services
  • Nipro Pharma Corporation-Major Partnerships and Agreements
33. The Last Word-Strategic Considerations for Staying on Growth Trajectory
  • Major Growth Opportunities
  • Major Growth Opportunities (continued)
  • Global API Outsourcing Scenario
  • Growth Opportunities in API Contract Manufacturing
  • Emerging CMO Business Model
  • Risk Sharing Model-Achievable by Sharing the Following Resources
  • Various Differentiation Strategies to Drive Long-term Profitability of CMOs
  • Global Pharmaceutical CMO Market-Final Word
  • Legal Disclaimer
34. Appendix
  • Market Engineering Methodology
  • List of Other Key Companies Included in This Research Service
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
- Aenova
- Baxter Biopharma Solutions
- Catalent
- Consort Medical
- Consort Medical (Aesica/Bespak)
- DTP Laboratories
- Famar
- Fareva
- Patheon
- Recipharm
- Vetter Pharma
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll